Organisation: Merrion H1

Sign in

Organisation: Merrion H1

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Merrion H1 profits down despite revenue increase

ISEQ-quoted Merrion Pharmaceuticals today reported a net loss of €2.3m for the six months to end June, compared to a loss of €2.1m for H1 2008.

Fri, 04 Sep, 2009